Caduceus Capital Partners
VC Fund
Brentwood, United States
Caduceus Capital Partners is a VC fund in Brentwood focused on Health Care and Software. Caduceus Capital Partners invest in great early-stage companies that recognize the seismic market shift driving unprecedented levels of innovation and digitization that enable new models of care delivery. It specializes in the fields of financial services, financial exchanges, and investment.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 95%
Last updated:
For AI agents: llms.txt
Industries Caduceus Capital Partners invests in
Stages Caduceus Capital Partners invests in
Countries Caduceus Capital Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dave Vreeland
|
|||
David Vreeland
|
|||
Scott Kolesar
|
|||
Investment Focus
Industry
- Health Care 10 (45%)
- Software 4 (18%)
- Artificial Intelligence 4 (18%)
- Medical 3 (14%)
- Personal Health 3 (14%)
Stage
- Seed 9 (41%)
- Series A 4 (18%)
- Pre-Seed 2 (9%)
- Venture - Series Unknown 2 (9%)
- Funding Round 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Dave Vreeland
Founder and Senior Managing Partner
|
Founder and Senior Managing Partner | Total investments: 8 | Find email | |
|
David Vreeland
Founder and Senior Managing Partner
|
Founder and Senior Managing Partner | Total investments: 0 | Find email | |
|
Scott Kolesar
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tombot
|
Tombot specializes in creating robotic animals and digital health solutions. The company targets a market of over 200 million individuals living with dementia or pre-dementia mild cognitive impairment. Research has demonstrated that robotic animals can effectively alleviate behavioral and psychological symptoms associated with dementia, includingloneliness, anxiety, depression, hallucinations, and violent anger, while also reducing the dependence on harmful psychotropic medications. Tombot’s mission is encapsulated in its tagline, "A dog for people who can’t have dogs. | $7M / Series A / Jun 25, 2026 | |
Cogensus
|
Cogensus is a proprietary digital health and analytics platform focused on cognitive health support, data insights, and legacy preservation. Our data collection engine engages patients to capture information both on cognitive progression and social determinants of health (SDOH). | Seed / Jun 04, 2026 | |
TrialClinIQ
|
TrialClinIQ bridges the gap between community health centers and clinical research. | $150K / Pre-Seed / Apr 28, 2026 | |
|
Tombot
|
Tombot specializes in creating robotic animals and digital health solutions. The company targets a market of over 200 million individuals living with dementia or pre-dementia mild cognitive impairment. Research has demonstrated that robotic animals can effectively alleviate behavioral and psychological symptoms associated with dementia, includingloneliness, anxiety, depression, hallucinations, and violent anger, while also reducing the dependence on harmful psychotropic medications. Tombot’s mission is encapsulated in its tagline, "A dog for people who can’t have dogs. | $6.1M / Series A / Jun 12, 2025 | |
BobiHealth
|
BobiHealth is a pregnancy tracking platform that combines extensive health data points with state-of-the-art ethical artificial intelligence (AI) and machine learning (ML) technology. | Seed / May 28, 2025 | |
|
Cogensus
|
Cogensus is a proprietary digital health and analytics platform focused on cognitive health support, data insights, and legacy preservation. Our data collection engine engages patients to capture information both on cognitive progression and social determinants of health (SDOH). | Pre-Seed / May 28, 2025 | |
Attune Media Labs
|
At Attune Media Labs, we have made the transformative power of meaningful connection available to everyone by developing Artificial Emotional Intelligence (AEI) and our scalable personal empathic companions, MiM. MiM is like talking to your friend on the phone. It’s your judgment-free confidant, available 24/7, on all your devices. Ourpatented process understands your vocal & facial expressions and combines those biometric data with our proprietary language model based on 50+ years of clinical psychoanalytic and neuroscience experience. By MiMicking how we communicate, MiM understands not just what you say but everything that goes unsaid. | Seed / May 28, 2025 | |
Elarin Health
|
Elarin is dedicated to assisting medical teams in preventing falls before they occur by utilizing real-time clinical information, personalized risk modeling, and explainable AI. | Seed / May 28, 2025 | |
TheraVista Health
|
TheraVista Health develops digital health solutions for physical therapy, focusing on vestibular rehabilitation. The company collaborates with NIH-funded researchers and CFD Research Corporation to create VestRx™, a comprehensive remote therapeutic monitoring platform. This platform aims to enhance therapy clinics' capabilities by integratinginnovative opportunities for patient care. | Seed / May 28, 2025 | |
Vie Science
|
Vie Science, Inc. is a digital health company dedicated to providing personalized fertility and reproductive wellness solutions through advanced technologies and data-driven insights. | Seed / May 28, 2025 | |
| See all 22 investments → | |||
Co-Investors
Revere Partners
3 deals together
Wavemaker 360
3 deals together
C2 Ventures
2 deals together
Dental Innovation Alliance
2 deals together
Ensemble Health Partners
2 deals together
Incisive Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Caduceus Capital Partners invest in?
Caduceus Capital Partners invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Caduceus Capital Partners?
Public channels for Caduceus Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Caduceus Capital Partners?
The team at Caduceus Capital Partners includes Dave Vreeland (Founder and Senior Managing Partner), David Vreeland (Founder and Senior Managing Partner) and Scott Kolesar (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
